[Pharmacotherapy of intestinal dysbacteriosis].
The article presents a summary of the published literature together with results of the author's own investigations designed to study pharmacotherapy of intestinal dysbacteriosis. Reasons for the origination of the above medical condition are given, the particulars of its clinical presentation are specified. Clinical-and-pharmacological properties of chylac forte, a new effective probiotic, are detailed.
Chekman
I S
IS
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D004359:Drug Therapy, Combination; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000382:microbiology; D019936:Probiotics / Q000008:administration & dosage / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents